RRx-001 (Oncology infusion formulation for Epicent Rx)
Vanton developed the formulation and Conduct the stability study. It is currently in Phase 2 open label trial.
The work includes:
- Feasibility study/Formulation development
- GLP manufacturing and management
- Stability testing
- Unconventional injection stability method development
- Injectability testing
